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Abstract
Background: By screening a plasmid library for proteins that could cause silencing when targeted
to the HMR locus in Saccharomyces cerevisiae, we previously reported the identification of Rtt107/
Esc4 based on its ability to establish silent chromatin. In this study we aimed to determine the
mechanism of Rtt107/Esc4 targeted silencing and also learn more about its biological functions.
Results: Targeted silencing by Rtt107/Esc4 was dependent on the SIR genes, which encode
obligatory structural and enzymatic components of yeast silent chromatin. Based on its sequence,
Rtt107/Esc4 was predicted to contain six BRCT motifs. This motif, originally identified in the human
breast tumor suppressor gene BRCA1, is a protein interaction domain. The targeted silencing
activity of Rtt107/Esc4 resided within the C-terminal two BRCT motifs, and this region of the
protein bound to Sir3 in two-hybrid tests. Deletion of RTT107/ESC4 caused sensitivity to the DNA
damaging agent MMS as well as to hydroxyurea. A two-hybrid screen showed that the N-terminal
BRCT motifs of Rtt107/Esc4 bound to Slx4, a protein previously shown to be involved in DNA
repair and required for viability in a strain lacking the DNA helicase Sgs1. Like SLX genes,
RTT107ESC4 interacted genetically with SGS1; esc4Δ sgs1Δ mutants were viable, but exhibited a
slow-growth phenotype and also a synergistic DNA repair defect.
Conclusion: Rtt107/Esc4 binds to the silencing protein Sir3 and the DNA repair protein Slx4 via
different BRCT motifs, thus providing a bridge linking silent chromatin to DNA repair enzymes.
Background
Transcriptional silencing in the budding yeast Saccharomy-
ces cerevisiae occurs at the silent mating-type loci HMR and
HML, telomeres, and at the rDNA locus. At all of these
silenced regions, DNA binding proteins recognize specific
motifs and recruit a silencing protein complex (reviewed
in [1]). HMR and HML are flanked by E and I "silencers."
Each silencer has binding sites for ORC, and Rap1 or Abf1.
The potent HMR-E silencer has a binding site for all three
proteins. At telomeres, Rap1 also contributes a critical
DNA-binding function, binding to the TG1–3 repeats.
At both the silent mating loci and at telomeres, the DNA-
binding proteins recruit a Sir protein complex that can
spread to silence genes at a distance (reviewed in [2]). At
HMR-E, for example, this is achieved by ORC recruitment
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binding to Sir4 and Sir3 [4,5]. Sir4 and Sir3 multimerize,
both with themselves and each other [4,6]. Sir4 also binds
Sir2, and Sir2 plays a crucial role in the spreading of a Sir2,
Sir3, Sir4 complex on chromatin by deacetylating histone
H4 lysine 16. The deacetylation produces a novel product,
2' O-acetyl-ADP-ribose [7-9]. This compound has recently
been shown to produce a conformational change in Sir3
that is likely to promote spreading of the Sir complex.
Sir2, Sir3 and Sir4 are essential for silencing at the HM loci
and at telomeres, while Sir1 plays a prominent role in
silencing at the mating type loci but not at telomeres. The
Yku70/Yku80 heterodimer that binds to DNA ends plays
an important role in silencing at telomeres, while being
dispensable for silencing at HM loci [10].
Deletion of the HMR-E silencer leads to loss of silencing
of genes at the HMR locus [11,12]. However, if heterolo-
gous DNA binding sites (such as Gal4 sites) are integrated
in place of HMR-E and the strain is transformed with cer-
tain Gal4 DNA binding domain (GBD) – silencing protein
hybrids, silencing can be restored due to targeting of Sir
proteins or proteins that bind to Sir proteins to HMR-E
([13]; see also Figure 1). This so-called "targeted silenc-
ing" has been a useful tool for investigating the process of
Sir protein recruitment to silenced loci [3,13-17]. We pre-
viously described a screen for proteins capable of targeted
silencing at HMR [16]. In this screen many known pro-
teins were identified, as well as several proteins not char-
acterized at the time, which we called Esc proteins because
they establish silent chromatin. One of these was Esc4
whose characterization we describe in this report.
RTT107/ESC4 was also identified in screens for mutants
with increased Ty transposon mobility or DNA repair
defects [18-20]. For simplicity we will only use the name
ESC4 in the remainder of this paper. Esc4 has been shown
to be phosphorylated by Mec1 kinase on SQ/TQ motifs in
response to DNA damage during S phase [21]. The phos-
phorylation by Mec1 has quite recently been proposed to
be regulated by Slx4, which was also shown to form a
complex containing Esc4 [22].
In this report we show that Esc4 has 6 BRCT motifs and
that they are important for its function. Many proteins
that function in repair, and even a silencing protein, Rap1,
contain BRCT (BRCA1 C-terminus) motifs. This motif was
first identified by database searching using the C-terminus
of the human breast cancer susceptibility protein, BRCA1
[23]. Since then, BRCT motifs from the human DNA
repair protein XRCC1 and the two tandem BRCT motifs of
BRCA1 protein have been crystallized [24,25] and crystal
and/or solution structures have also been solved of BRCTs
from 53BP1, DNA ligase III, and an NAD-dependent DNA
ligase [26-29]. More recently, it was discovered that BRCT
motifs could specifically bind to phosphoserine-contain-
ing proteins [30,31] and structures of such complexes
were subsequently also determined [32-34]. Overall,
BRCT motifs are thought to mediate a diverse array of pro-
tein-protein interactions, binding to proteins with differ-
ent structures, as well as to other BRCTs, both inter- and
intra-molecularly (reviewed in [35]).
DNA repair requires many DNA-modifying enzymes such
as nucleases, ligases, topoisomerases, polymerases and
helicases. Saccharomyces cerevisiae SGS1 is a member of the
RecQ family of genes encoding DNA helicases. In addi-
tion to Escherichia coli recQ, this helicase gene family
includes human BLM, WRN, RECQL, and Schizosaccharo-
myces pombe rqh1+. Members of the RecQ family of heli-
cases have been implicated in genomic stability, aging and
cancer. Yeast SGS1 has been shown by several labs to sup-
press DNA recombination, gross chromosomal rearrange-
ments, and Ty1 transposition, and to exhibit 3' to 5'
helicase activity [20,36-38]. Six SLX genes have been iso-
lated in a synthetic lethal screen using an sgs1Δ mutant
[39]. Two of these genes, SLX2 and SLX3, encode the
Mus81/Mms4 nuclease that acts on branched DNA struc-
tures. SLX1 is also predicted to be a nuclease, based on its
sequence [40]. Slx1 and Slx4 coimmunoprecipitate and
slx1 and slx4 mutants display similar phenotypes and have
been proposed to function together [39]. In addition, a
genome-wide genetic interaction (synthetic genetic array,
SGA) screen isolated a total of 24 genes that show a syn-
thetic growth interaction with an sgs1Δ mutation [41].
This screen identified 4 of the 6 SLX genes previously
identified in the sgs1Δ synthetic lethal screen described
above [39], as well as three other genes known to show
synthetic interactions [39,42-45]. The screen also identi-
fied 16 other genes that caused synthetic lethality or sick-
ness when mutated with sgs1Δ. One of these genes was
ESC4. Subsequently, there have been other reports con-
firming this genetic interaction between SGS1 and ESC4
[46,47].
Here we demonstrate that the C-terminal two BRCT
motifs of Esc4 bind to Sir3 and are sufficient for SIR-
dependent targeted silencing at HMR. Furthermore, the N-
terminal four BRCT motifs in Esc4 bind to Slx4, thus link-
ing this DNA repair protein to silent chromatin.
Results
Esc4 establishes targeted silencing when targeted to HMR
In a screen described previously, we identified Esc4 as a
protein that could restore silencing when targeted to an
HMR locus harboring a deletion of the HMR-E silencer
[16]. Targeting of proteins to HMR was mediated by the
binding of a Gal4 DNA binding domain (GBD)-hybrid
protein to a Gal4 DNA binding site (G) that replaced the
HMR-E silencer (Figure 1). Silencing was assessed using a
URA3 reporter gene integrated at the HMR locus.Page 2 of 12
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In order to understand how Esc4 promoted silencing
when targeted to the HMR locus, we tested silencing by
GBD-Esc4 in various strains. First, targeted silencing by
GBD-Esc4 was compared to GBD alone or to the potent tar-
geted silencing factor GBD-Esc1 in the strain in which the
screen was performed, which has the entire HMR-E
silencer deleted and replaced with a Gal4 DNA binding
site (HMR-E aeb::G) [17]. The fraction of cells silenced by
GBD-Esc4 was not as great as by GBD-Esc1 but, neverthe-
less, significant targeted silencing at HMR was observed
despite the complete absence of the HMR-E silencer (Fig-
ure 2, HMR-E aeb::G). When targeted silencing by GBD-
Esc4 was assessed in strains harboring deletions of just the
E and B sites (HMR-E Aeb::G) or the A and E sites (HMR-
E aeB::G) of the HMR-E silencer, silencing was increased
roughly 50 to 100-fold, as expected for strains with at least
one element of the natural silencer (Figure 2).
To test whether targeted silencing by GBD-Esc4 was SIR-
dependent, it was tested in strains deleted for the SIR2,
SIR3 or SIR4 genes. As seen in Figure 2, silencing by Esc4
required each of these SIR genes. This was expected since
targeted silencing by other proteins has been shown to be
SIR-dependent in every case examined previously [14,16].
It thus seemed likely that Esc4 caused silencing by recruit-
ing the Sir protein complex.
Saccharomyces Esc4 proteins contain six BRCT motifs and 
are homologous to S. pombe Brc1
Esc4 contains several copies of the BRCT motif, originally
identified in the human breast cancer susceptibility gene,
Esc4 was identified in an HMR targeted silencing screenFigure 1
Esc4 was identified in an HMR targeted silencing screen. (A) In the presence of both wild-type silencers, HMR-E and 
HMR-I, the URA3 reporter gene at HMR is completely silenced in a SIR-dependent manner leading to growth in the presence of 
the drug 5-FOA. (B) When the HMR-E silencer is deleted (and here replaced with a binding site for the Gal4 protein (G)), the 
HMR locus is no longer silenced and the URA3 reporter gene is expressed. This loss of silencing at hmr::URA3 leads to no 
growth on 5-FOA media. (C) When the strain in (B) is transformed with a GBD plasmid (GBD-X) capable of causing targeted 
silencing, this leads to restoration of silencing at hmr::URA3 and growth on 5-FOA. In this way, a GBD hybrid protein library was 
screened for factors capable of targeted silencing. A GBD-Esc4(1–1070) hybrid was identified.Page 3 of 12
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(encoded by yeast ORF YHR154w) has been observed pre-
viously by database searches [48,49], although there has
been disagreement as to how many BRCTs exist in this
protein, with some reports suggesting six BRCTs [49,50]
and others only four [21,22,48]. Our own analyses
including use of Pfam [51,52] confirms the first five puta-
tive BRCTs in Esc4, and it seems likely that residues 935–
1049, which are BRCT-like with a conserved W or Y resi-
due near the C-terminus, also form a domain that folds
into a BRCT type structure as previously reported [49]
(Figure 3). Furthermore, analysis of a homolog of Esc4
from S. pombe, Brc1, using Pfam shows six BRCTs in this
homologous protein, with the last two again being the
most alternative (E-values of 4.1 × 10-5 and 5.8 × 10-2 for
the fifth and sixth, respectively, compared to values rang-
ing from 2.8 × 10-6 to 1.7 × 10-14 for the first four BRCTs),
further supporting a conserved total of six motifs in these
homologs (Figure 3).
The six BRCT motifs of Esc4 protein exist as a set of four
tandem motifs at the N-terminus of the protein and two
more at the C-terminus (Figure 3, yellow lines). These two
sets of BRCT motifs are separated by a 375 amino acid
linker region. Although there are proteins from various
budding yeasts with compelling sequence similarity to S.
cerevisiae Esc4 (e.g. Ashbya gossipii, Kluyveromyces lactis, and
Candida glabrata, as shown in Figure 3), currently the only
obvious non-budding yeast homolog candidate is Brc1
from the evolutionarily distant fission yeast Schizosaccha-
Targeted silencing by Esc4 is SIR-dependentFigure 2
Targeted silencing by Esc4 is SIR-dependent. Targeted silencing by GBD-Esc4 (1–1070) was assessed in hmr::URA3 silenc-
ing reporter strains containing different HMR-E elements replaced by a Gal4 DNA binding site (G), similar to the situation 
shown in Figure 1B. A TRP1-marked plasmid expressing GBD alone served as a negative control and targeted silencing by the 
potent targeted silencing factor GBD-Esc1(1124–1658) served as a positive control [17]. Targeted silencing by GBD-Esc4 in 
strains with wild-type SIR genes (SIR+) or sir2Δ, sir3Δ, or sir4Δ mutations was examined.Page 4 of 12
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amino acids in length and also contains four BRCTs at the
N-terminus and two at the C-terminus, separated by a
linker region. Esc4 and Brc1 are 52% similar and 21%
identical overall. Human and mouse PTIP proteins have
been reported to be quite similar in sequence [21,53], but
do not contain the classically-conserved C-terminal aro-
matic residue present in all of the six BRCTs highlighted
with a red asterisk in the alignment shown in Figure 3.
Therefore, it is not yet clear if these proteins are bona fide
Esc4/Brc1 homologs.
The C-terminal two BRCT motifs of Esc4 are sufficient for 
targeted silencing
The Esc4 hybrid protein isolated in our targeted silencing
screen was full-length [16] and therefore contained all six
predicted BRCT motifs. To determine which part of Esc4
and which BRCT motifs were responsible for the SIR-
dependent targeted silencing, we constructed three GBD
hybrids: one to the N-terminal four BRCT motifs (GBD-
Esc4N, aa 1–480), one to the linker between the N- and C-
terminal sets of motifs (GBD-Esc4L, aa 480–836), and one
to the C-terminal two BRCT motifs (GBD-Esc4C, aa 818–
Saccharomyces cerevisiae Esc4 has six BRCT motifs that are conserved in both sequence and domain architecture among yeast homologsFigure 3
Saccharomyces cerevisiae Esc4 has six BRCT motifs that are conserved in both sequence and domain architec-
ture among yeast homologs. The six BRCT motifs in Esc4 are indicated with brackets and yellow color and were described 
previously [49]. The motifs in Esc4 are shown as they align with a subset of Esc4 homologs: three from other budding yeasts 
Ashbya gossipii, Kluyveromyces lactis and Candida glabrata and one from the evolutionarily distant fission yeast Schizosaccharomyces 
pombe Brc1. The highly conserved aromatic residue, a hallmark of BRCT motifs, is marked above the alignment with a red 
asterisk. Blue color indicates similarity with the predominant residue at the position in the alignment, with darkness correlated 
with greater similarity as calculated by ClustalW software and displayed with Jalview alignment editor's BLOSUM62 score view-
ing option [67, 68].Page 5 of 12
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in a strain harboring deletions of the E and B sites (HMR-
E Aeb::G) and in a sir2Δ derivative of that strain (Figure 4;
see Table 1 for strain information). Significant targeted
silencing was observed by GBD-Esc4C, although it was not
as much as with full-length Esc4. The observed silencing
by GBD-Esc4C was SIR-dependent, as observed for the full-
length protein (Figure 2). No significant silencing was
seen with Esc4N or with the linker region, Esc4L (Figure
4).
The C-terminal BRCT motifs of Esc4 interact with Sir3
Because the C-terminal two BRCT motifs of Esc4 gave tar-
geted silencing, we suspected that this region of the pro-
tein was binding to a silencing protein to recruit the Sir
complex. Using a LexA-Esc4C hybrid and the two-hybrid
reporter strain L40 [54], we tested for two-hybrid interac-
tions with several Gal4 activation domain (GAD)-silenc-
ing protein constructs, including Sir1, Sir2, Sir3, Sir4 and
Rap1 [3,17,55]. A strong interaction (i.e., the lacZ reporter
gene generated blue color from X-gal visible in 15 min-
utes) with GAD-Sir3 (aa 252–978) was identified, as well
as a weaker interaction with GAD-Sir4 (aa 839–1358)
(Table 2). None was detected with Sir1, Sir2 or Rap1.
Because the GAD-Sir4 (aa 839–1358) hybrid contained
the region known to bind to Sir3 [7], we hypothesized
that LexA-Esc4 was binding to GAD-Sir4 via a bridge of
endogenous Sir3. To test this, we used a derivative of
strain L40 harboring a sir3Δ mutation and examined the
LexA-Esc4 interaction with GAD-Sir4. In this case, the
interaction with GAD-Sir4 was no longer observed,
whereas the interaction with GAD-Sir3 and an unrelated
two-hybrid control interaction were unaffected (Table 2).
When a sir4Δ derivative of L40 was used, no change in the
LexA-Esc4 interactions with GAD-Sir3 or GAD-Sir4 was
observed, further supporting the idea that Esc4 requires
Sir3 to interact with Sir4, and not vice versa. Taken
together, the targeted silencing data strongly suggest an
interaction (probably a direct one) between the C-termi-
nal BRCT motifs and the silencing protein Sir3.
The N-terminal four BRCT motifs of Esc4 bind to Slx4
The above results indicated that Esc4 caused SIR-depend-
ent targeted silencing primarily by binding to Sir3
through its C-terminal two BRCT motifs. In addition, Esc4
also contains four BRCT motifs at its N-terminus and
these BRCT motifs are more similar to those found in var-
ious proteins from diverse eukaryotes (Figure 3, and ref.
[49]). In order to identify proteins that bind to these N-
terminal BRCT motifs, a two-hybrid screen was performed
using a LexA-Esc4N (aa 1–480) fusion protein. Strikingly,
from screening ~2 × 107 library plasmids expressing GAD
protein hybrids, thirteen clones containing in-frame
fusions of GAD to Slx4 were identified (Table 3). In-frame
GAD fusions to the six different positions in Slx4 were iso-
lated (see Table 3) and all contained at least the C-termi-
nal half of the protein (residues 383–748). The Esc4N-
Slx4C two-hybrid interaction was a very strong one and
was specific. Also, Slx4 did not show an interaction with
Esc4C. Thus, the N-terminal BRCT motifs of Esc4 are not
only necessary for binding Slx4, as reported while this
manuscript was in preparation [22], but are indeed suffi-
cient for this interaction in vivo. Furthermore, our two-
hybrid data show that the region of Slx4 sufficient for Esc4
binding resides in its C-terminus.
Genetic and phenotypic analysis of ESC4
A heterozygous diploid strain with a complete deletion of
ESC4 was constructed and dissected to generate a null
mutant haploid. This esc4Δ mutant grew normally and
also mated with normal efficiency (suggesting no gross
defect in HM silencing). Furthermore, when an esc4Δ
mutation was introduced into a strain with a telomere
reporter gene, no telomeric silencing defect was seen (data
not shown). Thus, although Esc4 binds to Sir3, Esc4 does
not appear to be a protein required for Sir protein-medi-
ated silencing.
The BRCT motif was originally identified in the human
BRCA1 tumor suppressor protein [23]. BRCA1 functions
in DNA repair and DNA damage-sensing in cell cycle
checkpoints (reviewed in [56]). As shown in Figure 5,
strains deleted for ESC4 grew significantly less well than
wild type on medium containing either MMS or HU. This
result confirms reports that have since been published
[18,21,22,46], as does our observation that esc4Δ mutants
are not sensitive to ultraviolet radiation [18,21] (data not
shown).
As shown in Figure 5, like esc4Δ mutants, slx4Δ mutants
were sensitive to 0.032% MMS. Furthermore, the esc4Δ
slx4Δ double mutant did not exhibit a greater MMS sensi-
tivity than either single mutant (Figure 5A and data not
shown), suggesting that they cooperate in providing
resistance to MMS. Another group reported that an esc4Δ
slx4Δ double mutant was more sensitive than either single
mutant but the difference was very slight [22]. In contrast,
an esc4Δ, but not a slx4Δ mutant, was significantly HU-
sensitive, and the double mutant was no more sensitive
than the esc4Δ strain. Thus, Esc4 appears to act independ-
ently of Slx4 in providing resistance to HU.
Because Esc4 bound to Slx4 and because the mutant was
sensitive to MMS, this suggested that Esc4 might function
in the same pathway as Slx4. SLX4 was first identified in a
screen for genes required for viability of yeast cells deleted
for SGS1 [39]. Therefore, we tested if esc4 was also syn-
thetically lethal with sgs1. To do this, an esc4Δ mutant was
crossed with an sgs1Δ mutant, the diploid was sporulated
and dissected and meiotic progeny were analyzed. Hap-Page 6 of 12
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slower-growing that either single mutant (e.g., see Figure
5, YPD plate). While this work was in progress, this
genetic interaction was also observed in genome-wide
studies [41,46].
An sgs1Δ mutant showed sensitivity to both MMS and HU
(Figure 5), as expected based on previously published
results. An asf1Δ mutant was used as a control and dis-
played sensitivity to both DNA damaging chemicals, as
expected [57,58]. Interestingly, an esc4Δ sgs1Δ mutant dis-
played MMS and HU sensitivity that was much more pro-
nounced than that of either single mutant (Figure 5A and
5B). The enhanced sensitivity of this double mutant
(10,000-fold on 0.014% MMS plates) seemed to be due to
a synergistic repair defect and not entirely due to the
growth defect (10-fold difference in colony number on
YPD control plates) that was also observed in the esc4Δ
sgs1Δ strain.
Discussion
By screening a library of factors that could function in
place of the HMR-E silencer when targeted to DNA, we
identified Esc4 for its ability to establish silent chromatin
[16]. Protein sequence analysis showed that Esc4 protein
contains six BRCT motifs; four are found in tandem at the
amino-terminus and two more are at the carboxy-termi-
nus. The entire Esc4 protein was present in the hybrid
identified in the targeted silencing screen. Since targeted
silencing by Esc4 at HMR was found to be SIR-dependent,
it seemed likely that some region within Esc4 was attract-
ing a silencing protein complex to DNA. We tested subsets
of the BRCT motifs, as well as the linker between them, for
targeted silencing at HMR. These experiments demon-
strated that the C-terminal two BRCTs caused targeted
silencing that was nearly as strong as with full-length Esc4.
Because silencing by this pair of BRCT motifs of Esc4 was
also SIR-dependent, it seemed very likely that this region
was recruiting a Sir protein when tethered to DNA. There-
fore, we tested the C-terminal BRCT motifs for interac-
tions with known silencing proteins by two-hybrid
analysis. We identified a specific interaction with Sir3 (aa
252–978). We conclude that binding of Sir3 by Esc4 is
likely to be responsible for the SIR-dependent targeted
silencing activity.
In some cases BRCT motifs have been shown to bind to
phosphorylated serine residues. Specifically, they have
been shown to bind to phosphopeptides with the follow-
ing consensus: pSxxF [32]. Interestingly, Sir3 has an SxxF
Targeted silencing activity is achieved by the C-terminus of Esc4Figure 4
Targeted silencing activity is achieved by the C-terminus of Esc4. Three different regions of Esc4, containing either 
the first four BRCT motifs (1–480), linker region (480–836), or last two BRCTs (818–1070) were tested for targeted silencing 
in a strain with an HMR-E Aeb::G silencer and URA3 reporter gene at HMR. GBD-Esc1 served as a potent positive control and 
GBD as a negative control. SIR2-dependence of targeted silencing was also determined.Page 7 of 12
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that we describe here (aa 252–978) and, furthermore, Sir3
protein has been shown to be phosphorylated [59,60],
suggesting that an Esc4 BRCT motif or perhaps the combi-
nation of the two in the C-terminus may bind to phos-
pho-Sir3. However, not all proteins bound by BRCT
motifs have the SxxF motif [61], so the precise BRCT-inter-
acting region of Sir3 could be elsewhere.
In addition to binding Sir3 via C-terminal tandem BRCT
motifs, Esc4 also binds to Slx4 via four tandem N-terminal
BRCTs, as we have shown here by two-hybrid screening.
This two-hybrid result demonstrates that these four BRCTs
are sufficient for binding Slx4 and agrees with a recent
report showing that the N-terminal BRCT motifs are
required for this interaction [22]. It seems quite possible
that Esc4 could bind Sir3 and Slx4 concurrently, given that
these nuclear proteins' binding sites within Esc4 map to
BRCT clusters separated by a long linker. Slx4 has been
shown to heterodimerize with the endonuclease Slx1 to
cleave DNA containing 5' -flap structures, such as in
stalled replication forks, to facilitate their repair [62].
Thus, Esc4 binds the silencing protein Sir3 and also to
Slx4, an important DNA repair complex component. Esc4
may play a role in facilitating repair of aberrant DNA
structures, perhaps specifically within silent chromatin.
Table 2: Esc4 binds to Sir3 in the two-hybrid system
Interaction in two-hybrid strainsa
LexA hybrid GAD hybrid L40 L40 Δ sir3 L40 Δ sir4
LexA-Esc4 (818–1070) GAD-Sir3 (252–978) ++ ++ ++
LexA-Esc4 (818–1070) GAD-Sir4 (839–1358) + - +
LexA-Esc4 (818–1070) GAD vector - - -
LexA-Esc4 (1–480) GAD-Slx4 (383–748) +++ +++ +++
a Three +++ signs means an easily visible blue color from the lacZ reporter gene was visible within 15 minutes, whereas two ++ signs means it was 
visible within 30 minutes and one + sign means it was visible between 40 minutes and two hours.
Table 1: Yeast strains used in this study
Strain Genotype Reference or Source
W303-1a MATaleu2–3,112 ura3-1 his3–11,15 trp1–1 
ade2-1 can1–100
R. Rothstein
W303-1b MATα version of W303-1a R. Rothstein
W303 Diploid from W303-1a × W303-1b This study
YDZ5 W303 MATa/MATα esc4Δ::his5+/ESC4 This study
YDZ174 W303 MATa/MATα esc4Δ::his5+/esc4Δ::his5+ This study
YDZ3 W303-1a esc4Δ::his5+ This study
YDZ4 W303-1b esc4Δ::his5+ This study
YEA78 W303-1b hmr::URA3 HMR-E (aeb::G) gal4::LEU2 This study
YEA76 YEA78 but HMR-E (Aeb::G) This study
YEA77 YEA78 but HMR-E (aeB::G) Thi study
YAM7 YEA76 sir2Δ::kanMX6 This study
YEA118 YEA76 but GAL4 sir3::LEU2 This study
YKAB17 YEA76 sir4Δ::kanMX6 This laboratory
YDS631 W303-1b adh4::URA3-(C1–3A)n [13]
YDZ22 YDS631 esc4Δ::his5+ This study
YAM1 W303-1a slx4Δ::his5+ This study
YAM2 W303-1b slx4Δ::his5+ This study
YAM3 W303-1a slx4Δ::kanMX6 This study
YAM4 W303-1b slx4Δ::kanMX6 This study
YAM13 W303-1b sgs1Δ::kanMX6 This study
YDZ243 W303-1_ sgs1Δ::kanMX6 esc4Δ::his5+ This study
YAM6 W303-1a esc4Δ::his5+slx4Δ::kanMX6 This study
YAS501 W303-1a asf1Δ::his5+ This laboratory
L40 MATahis3Δ200 trp1–901 leu2–3,112 ade2 
URA3::(lexAop)8-lacZ LYS2::(lexAop)4-HIS3
[54]
YRJ3 L40 sir3Δ::kanMX6 This study
YJL103 L40 sir4Δ::kanMX6 This studyPage 8 of 12
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is required for its repair function. It is possible that phos-
phorylation of Esc4 by Mec1, which occurs just N-termi-
nal to the Sir3-binding BRCTs, regulates association with
Sir3 or other factors required for its ability to repair partic-
ular chromosomal loci in S phase.
We analyzed Esc4 protein alignments (such as that shown
in Figure 3) for evidence of conserved regions in the pro-
tein other than BRCT motifs. One region of interest was
the SQ/TQ motifs between amino acids 743 and 807,
which were shown to be important for function in DNA
repair [21]. We did not find that these motifs were well-
Table 3: The amino-terminal BRCT motifs of Esc4 bind to Slx4
LexA hybrid GAD hybrid Number of isolates
LexA-Esc4 (1–480) GAD-Slx4 (166–748) 1
LexA-Esc4 (1–480) GAD-Slx4 (194–748) 2
LexA-Esc4 (1–480) GAD-Slx4 (260–748) 1
LexA-Esc4 (1–480) GAD-Slx4 (280–748) 4
LexA-Esc4 (1–480) GAD-Slx4 (368–748) 3
LexA-Esc4 (1–480) GAD-Slx4 (383–748) 2
Genetic evidence that ESC4 and SLX4 function together in a parallel pathway to SGS1 for repair of damaged DNAFigure 5
Genetic evidence that ESC4 and SLX4 function together in a parallel pathway to SGS1 for repair of damaged 
DNA. Strains were grown in YPD medium to saturation and then ten-fold serial dilutions were spotted onto YPD, YPD + HU 
(100 mM), or YPD + MMS (0.032% in part A and 0.014% in part B) media. Cells were incubated at 30°C for 2 days (SC and SC 
+ MMS) or 3 days (SC + HU) before being photographed. WT, wild type. An asf1Δ mutant was used as a positive control for 
MMS and HU sensitivity.Page 9 of 12
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ylation is not particularly critical in proteins with other-
wise similar overall BRCT domain architecture (i.e.,
[BRCT]4-linker-[BRCT]2 arrangement). This may be
because of some differences in Esc4 functions in diverse
yeasts or may suggest that flexibility is tolerated in posi-
tioning of the phosphorylation sites, and therefore the
exact relative location of kinase target sites has not been
constrained during evolution.
Future structural and genome sequencing studies are
likely to unveil similarities and differences between multi-
BRCT domain containing proteins. Whether these pro-
teins play largely protein-scaffolding roles or also contain
intrinsic enzymatic properties will be interesting to dis-
cover.
Conclusion
We have shown that Esc4 caused targeted silencing when
tethered at a weakened HMR locus. The targeted silencing
activity was primarily due to the C-terminal two tandem
BRCT motifs in Esc4, which bound to Sir3, probably
through a direct interaction. This interaction led to the
recruitment of the Sir complex and hence caused targeted
silencing. The N-terminal BRCT domains were sufficient
for binding to Slx4, which functions with Esc4 in DNA
repair. Thus, the nuclear Esc4 protein uses its six BRCT




Esc4 was identified in a targeted silencing screen that has
been described previously [16]. Briefly, a Gal4 DNA bind-
ing domain (GBD) library was screened for hybrid proteins
capable of establishing silencing of a URA3 reporter gene
integrated in place of mating-type genes at an HMR locus
that had the HMR-E silencer replaced by a Gal4 DNA
binding site (G) (see Figure 1A). A full length GBD-Esc4
(1–1070) clone, aeb15, was identified as being capable of
establishing targeted silencing of hmr::URA3, causing
resistance to 5-fluororotic acid (5-FOA). This GBD-Esc4
clone was subsequently transformed into strain YEA76
(HMR-E Aeb::G hmr::URA3 gal4::LEU2) and YEA77
(HMR-E aeB::G hmr::URA3 gal4::LEU2) (see Table 1 and
Yeast Strain section for details) and tested for targeted
silencing. To test SIR-dependence of targeted silencing by
Esc4 at HMR, shown in Figure 4, targeted silencing in
strain YEA76 (SIR+) was compared with that in sir mutant
derivatives YAM7 (sir2Δ), YEA 118 (sir3Δ), and YKAB17
(sir4Δ).
For the targeted silencing experiments shown in Figures 2
and 4, assays were carried out as follows: strains were
transformed with plasmids expressing the appropriate
GBD hybrid protein, grown at 30°C for two days in SC -Trp
medium (to select for the GBD plasmid), serially diluted
ten-fold five times and spotted on SC -Trp + 5-FOA plates
(to assay for silencing at HMR) or on SC -Trp control
plates.
Plasmids
Plasmid aeb15, expressing GBD-Esc4(1–1070) was iso-
lated in the targeted silencing screen. This plasmid was
recovered from a library based on pGBT9.C (ADH1UAS-
GBD, TRP1, CEN4/ARS1; see Acknowledgements). To gen-
erate plasmids for use in the two-hybrid system, ESC4
sequences were amplified from genomic DNA and sub-
cloned into plasmid pSTT91, a derivative of pBTM116
that contains the ADE2 gene ([63]; see also [64]). Plas-
mids pAM2 (LexA-Esc4N (a.a. 1–480) and pAM7 (LexA-
Esc4C (a.a. 818–1070) were used for two-hybrid experi-
ments. To test for LexA-Esc4C binding to GAD-Sir3 and
GAD-Sir4, plasmid pEDA195, GAD-Sir3(252–978), and
pCTC36, GAD-Sir4(839–1358), were used. pCTC36
expresses the same region of SIR4 as plasmid pCTC18 [55]
except that the Sir4 hybrid is expressed from pGAD-R.
pEDA195 was constructed by cloning a PstI fragment of
the SIR3 gene into vector pGAD424. Plasmid pAM2,
expressing LexA-Esc4(1–480), and a clone expressing
GAD-Slx4(383–748) isolated in the two-hybrid screen
were used as a positive control in two-hybrid experiments
summarized in Table 3.
Yeast strain construction
All strains are listed in Table 1. To make slx1Δ, slx4Δ, sir2Δ,
sir4Δ, and sgs1Δ mutants, PCR primers with 5' homology
to sequences flanking these ORFs and 3' homology to
sequences in a plasmids harboring selectable marker
genes were used for PCR, generating targeting cassettes
that were transformed into yeast as has been previously
described [65]. esc4Δ ::his5+ mutants were generated by
the same method, but using a different plasmid as a tem-
plate for PCR (gift of N. Dean, Stony Brook University).
Strain YEA76 and its derivatives are derived from strain
YSB35 [13].
Two-hybrid screening and direct tests
Screening was performed essentially as described [54,63].
Plasmid pAM2, which expresses LexA-Esc4(1–480),
(ADE2, TRP1, 2μ) was co-transformed with approxi-
mately 1 μg of GAD library (LEU2, 2μ; [66]) into strain
L40 [54], which contains LexA binding sites upstream of
both the HIS3 gene and the LacZ gene. The following spe-
cificity tests were performed: (1) His+ candidates were
assayed for lacZ expression both after curing candidates of
either the LexA or the GAD plasmid, (2) GAD hybrids
were tested for interactions with nonspecific LexA hybrids
(e.g. LexA-lamin) by mating candidates cured of the bait
plasmid to LexA-containing AMR70 [54], and (3) thePage 10 of 12
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tests were subsequently retransformed into L40 along the
original bait and tested for LacZ expression.
Two-hybrid tests done using the C-terminal BRCT motifs
in Esc4 were performed by co-transforming L40 with plas-
mid pAM7, expressing LexA-Esc4(818–1070), and various
GAD hybrids to silencing proteins, such as Sir1, Sir2, Sir3,
Sir4, and Rap1. To test whether Sir3 bridged binding of
LexA-Esc4(818–1070) to Sir4, a sir3Δ::kanMX6 derivative
of L40 was generated (see yeast strains section for details),
strain YRJ3, and the interaction was then retested in this
strain. The control sir4Δ-derivative of L40 used was strain
YJL03.
DNA damage sensitivity tests
Cultures were grown in YPD medium ~18 h at 30°C and
then serially diluted ten-fold, five times before being spot-
ted onto plates containing YPD medium with MMS, HU,
or no chemical. Cells were then incubated at 30°C and, in
the case of MMS media, the plates were wrapped in alumi-
num foil.
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